Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.
Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E. Cunningham D, et al. Among authors: mueser m. N Engl J Med. 2004 Jul 22;351(4):337-45. doi: 10.1056/NEJMoa033025. N Engl J Med. 2004. PMID: 15269313 Free article. Clinical Trial.
Cetuximab plus irinotecan in pretreated metastatic colorectal cancer patients: the ELSIE study.
Lim R, Sun Y, Im SA, Hsieh RK, Yau TK, Bonaventura A, Cheirsilpa A, Esser R, Mueser M, Advani S. Lim R, et al. Among authors: mueser m. World J Gastroenterol. 2011 Apr 14;17(14):1879-88. doi: 10.3748/wjg.v17.i14.1879. World J Gastroenterol. 2011. PMID: 21528063 Free PMC article. Clinical Trial.
Pharmacokinetic profile of cetuximab (Erbitux) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma.
Delbaldo C, Pierga JY, Dieras V, Faivre S, Laurence V, Vedovato JC, Bonnay M, Mueser M, Nolting A, Kovar A, Raymond E. Delbaldo C, et al. Among authors: mueser m. Eur J Cancer. 2005 Aug;41(12):1739-45. doi: 10.1016/j.ejca.2005.04.029. Eur J Cancer. 2005. PMID: 16051481 Clinical Trial.
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.
Chan AT, Hsu MM, Goh BC, Hui EP, Liu TW, Millward MJ, Hong RL, Whang-Peng J, Ma BB, To KF, Mueser M, Amellal N, Lin X, Chang AY. Chan AT, et al. Among authors: mueser m. J Clin Oncol. 2005 May 20;23(15):3568-76. doi: 10.1200/JCO.2005.02.147. Epub 2005 Apr 4. J Clin Oncol. 2005. PMID: 15809453 Clinical Trial.
The response of two different dosages of beclometasone dipropionate suspension for nebulization versus a standard dose of beclometasone dipropionate via a metered-dose inhaler on bronchoprovocation testing in adults with asthma.
Bousquet J, Meziane H, Chanez P, Mueser M, Umile A. Bousquet J, et al. Among authors: mueser m. Respir Med. 2003 Feb;97 Suppl B:S11-4. Respir Med. 2003. PMID: 12593522 Free article. Clinical Trial.
Disability related to COPD tool (DIRECT): towards an assessment of COPD-related disability in routine practice.
Aguilaniu B, Gonzalez-Bermejo J, Regnault A, Barbosa CD, Arnould B, Mueser M, Granet G, Bonnefoy M, Similowski T. Aguilaniu B, et al. Among authors: mueser m. Int J Chron Obstruct Pulmon Dis. 2011;6:387-98. doi: 10.2147/COPD.S20007. Epub 2011 Jul 5. Int J Chron Obstruct Pulmon Dis. 2011. PMID: 21760726 Free PMC article.
[The profile of the patients referred by general practitioners to respiratory physicians for assessment of undiagnosed bronchial disease].
Escamilla R, Grignet JP, Bourcereau J, Mueser M. Escamilla R, et al. Among authors: mueser m. Rev Mal Respir. 2010 May;27(5):463-71. doi: 10.1016/j.rmr.2010.03.007. Rev Mal Respir. 2010. PMID: 20569879 French.
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.
Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Yu CT, Ganul V, Roh JK, Bajetta E, O'Byrne K, de Marinis F, Eberhardt W, Goddemeier T, Emig M, Gatzemeier U; FLEX Study Team. Pirker R, et al. Lancet. 2009 May 2;373(9674):1525-31. doi: 10.1016/S0140-6736(09)60569-9. Lancet. 2009. PMID: 19410716 Clinical Trial.
[The "Compli'Asthme" therapeutic observation survey on good use of inhaled drugs for asthma: perception by general practitioners].
Megas F, Benmedjahed K, Lefran├žois G, Mueser M, Dusser D. Megas F, et al. Among authors: mueser m. Rev Pneumol Clin. 2004 Jun;60(3):158-65. doi: 10.1016/s0761-8417(04)72091-x. Rev Pneumol Clin. 2004. PMID: 15292825 French.